SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-22-238845
Filing Date
2022-09-06
Accepted
2022-09-06 16:07:34
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 d390116d424b3.htm 424B3 343349
2 EX-FILING FEES d390116dexfilingfees.htm EX-FILING FEES 56894
3 GRAPHIC g390116g02a01.jpg GRAPHIC 35015
4 GRAPHIC g390116g94j64.jpg GRAPHIC 35104
  Complete submission text file 0001193125-22-238845.txt   491303
Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-259955 | Film No.: 221228329
SIC: 2836 Biological Products, (No Diagnostic Substances)